Artikel ; Online: Rotavirus spike protein ΔVP8* as a novel carrier protein for conjugate vaccine platform with demonstrated antigenic potential for use as bivalent vaccine.
2021 Band 11, Heft 1, Seite(n) 22037
Abstract: Conjugate vaccine platform is a promising strategy to overcome the poor immunogenicity of bacterial polysaccharide antigens in infants and children. A carrier protein in conjugate vaccines works not only as an immune stimulator to polysaccharide, but ... ...
| Abstract | Conjugate vaccine platform is a promising strategy to overcome the poor immunogenicity of bacterial polysaccharide antigens in infants and children. A carrier protein in conjugate vaccines works not only as an immune stimulator to polysaccharide, but also as an immunogen; with the latter generally not considered as a measured outcome in real world. Here, we probed the potential of a conjugate vaccine platform to induce enhanced immunogenicity of a truncated rotavirus spike protein ΔVP8*. ΔVP8* was covalently conjugated to Vi capsular polysaccharide (Vi) of Salmonella Typhi to develop a bivalent vaccine, termed Vi-ΔVP8*. Our results demonstrated that the Vi-ΔVP8* vaccine can induce specific immune responses against both antigens in immunized mice. The conjugate vaccine elicits high antibody titers and functional antibodies against S. Typhi and Rotavirus (RV) when compared to immunization with a single antigen. Together, these results indicate that Vi-ΔVP8* is a potent and immunogenic vaccine candidate, thus strengthening the potential of conjugate vaccine platform with enhanced immune responses to carrier protein, including ΔVP8*. |
|---|---|
| Mesh-Begriff(e) | Animals ; Humans ; Immunization ; Mice ; Polysaccharides, Bacterial/immunology ; Polysaccharides, Bacterial/pharmacology ; Rotavirus/immunology ; Rotavirus Infections/immunology ; Rotavirus Infections/prevention & control ; Salmonella typhi/immunology ; Typhoid Fever/immunology ; Typhoid Fever/prevention & control ; Vaccines, Combined/immunology ; Vaccines, Combined/pharmacology ; Vaccines, Conjugate/immunology ; Vaccines, Conjugate/pharmacology ; Viral Proteins/immunology ; Viral Proteins/pharmacology |
| Chemische Substanzen | Polysaccharides, Bacterial ; Vaccines, Combined ; Vaccines, Conjugate ; Viral Proteins |
| Sprache | Englisch |
| Erscheinungsdatum | 2021-11-11 |
| Erscheinungsland | England |
| Dokumenttyp | Journal Article |
| ZDB-ID | 2615211-3 |
| ISSN | 2045-2322 ; 2045-2322 |
| ISSN (online) | 2045-2322 |
| ISSN | 2045-2322 |
| DOI | 10.1038/s41598-021-01549-z |
| Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.